AHA: Five-Year Risk for Prediabetes Progression Varies in Young Adults

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on March 19, 2026.

via HealthDay

THURSDAY, March 19, 2026 -- Among young adults, five-year progression from prediabetes to type 2 diabetes is highest among those who meet glucagon-like peptide-1 receptor agonist (GLP-1 RA) eligibility criteria and have fasting glucose of 110 to 125 mg/dL, according to a study presented at the American Heart Association Epidemiology and Prevention/Lifestyle and Cardiometabolic Health 2026 Scientific Sessions, held from March 17 to 20 in Boston.

Mary Rooney, Ph.D., M.P.H., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues characterized five-year risk and risk factors for progression to diabetes in young adults with prediabetes. The analysis included pooled data from 662 participants (aged 18 to 40 years) with prediabetes (fasting glucose of 100 to 125 mg/dL) participating in one of three cohorts.

The researchers found that the five-year risk for progression from prediabetes to diabetes was 7.5 percent. Among young adults with prediabetes who met GLP-1 RA eligibility criteria for weight loss, five-year progression risk was 10.9 percent. For those with fasting glucose of 110 to 125 mg/dL, five-year risk was 15.1 percent. Five-year risk for diabetes was highest (24.8 percent) for young adults who met GLP-1 RA eligibility criteria and had fasting glucose of 110 to 125 mg/dL, which was nearly fivefold higher than for those meeting neither criteria.

"Our results signal that some people with prediabetes have a higher risk of progressing to type 2 diabetes," Rooney said in a statement. "These are the patients who may benefit from more targeted, intensive treatment than others."

One author disclosed ties to Siemens Healthineers.

Press Release

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-03-20 01:53

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

AHA: Five-Year Risk for Prediabetes Progression Varies in Young Adults

Read more

Disclaimer

Popular Keywords